ULTRAGENYX PHARMACEUTICAL INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.5 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-06
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 15.50 shares, a 7.74% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 16.83M shares, a 0.56% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 17.39M shares, a 2.21% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 16.80 shares, a 100.00% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.29M shares, a 15.05% increase from fiscal 2023.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.16M shares, a 25.33% increase from fiscal 2022.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 11.30M shares, a 37.49% increase from fiscal 2021.
- ULTRAGENYX PHARMACEUTICAL INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 8.22M shares, a 4.05% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | 15.50 shares 10-Q · filed 2026-05-06 | ||||
| 2025-09-30 | 16.83M shares 10-Q · filed 2025-11-05 | 16.97M shares 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 17.39M shares 10-Q · filed 2025-08-06 | 17.04M shares 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | 16.80 shares 10-Q · filed 2026-05-06 | 16.79M shares 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | 16.29M shares 10-K · filed 2025-02-19 | ||||
| 2024-09-30 | 16.73M shares 10-Q · filed 2025-11-05 | 16.27M shares 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | 17.02M shares 10-Q · filed 2025-08-06 | 16.04M shares 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | 15.17M shares 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | 14.16M shares 10-K · filed 2025-02-19 | ||||
| 2023-09-30 | 14.65M shares 10-Q · filed 2024-11-06 | 14.15M shares 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | 14.94M shares 10-Q · filed 2024-08-02 | 13.89M shares 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | 12.92M shares 10-Q · filed 2024-05-03 | ||||
| 2022-12-31 | 11.30M shares 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | 12.01M shares 10-Q · filed 2023-11-03 | 11.13M shares 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | 12.00M shares 10-Q · filed 2023-08-04 | 10.69M shares 10-Q · filed 2023-08-04 | |||
| 2022-03-31 | 9.39M shares 10-Q · filed 2023-05-05 | ||||
| 2021-12-31 | 8.22M shares 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | 8.32M shares 10-Q · filed 2022-11-03 | 8.30M shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 8.50M shares 10-Q · filed 2022-07-29 | 8.29M shares 10-Q · filed 2022-07-29 | |||
| 2021-03-31 | 8.12M shares 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | 8.56M shares 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | 8.66M shares 10-Q · filed 2021-11-03 | 8.70M shares 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | 5.21M shares 10-Q · filed 2021-08-03 | 8.71M shares 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | 8.59M shares 10-Q · filed 2021-05-05 | ||||
| 2019-12-31 | 8.13M shares 10-K · filed 2022-02-15 | ||||
| 2019-09-30 | 8.34M shares 10-Q · filed 2020-10-27 | 8.10M shares 10-Q · filed 2020-10-27 | |||
| 2019-06-30 | 8.38M shares 10-Q · filed 2020-07-30 | 7.98M shares 10-Q · filed 2020-07-30 | |||
| 2019-03-31 | 7.62M shares 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | 7.45M shares 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | 7.42M shares 10-Q · filed 2019-11-06 | 7.56M shares 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | 7.89M shares 10-Q · filed 2019-08-02 | 7.63M shares 10-Q · filed 2019-08-02 | |||
| 2018-03-31 | 5.15M shares 10-Q · filed 2019-05-07 | ||||
| 2017-12-31 | 6.02M shares 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | 6.02M shares 10-Q · filed 2018-11-06 | 5.90M shares 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | 5.92M shares 10-Q · filed 2018-08-03 | 5.69M shares 10-Q · filed 2018-08-03 | |||
| 2017-03-31 | 5.48M shares 10-Q · filed 2018-05-08 | ||||
| 2016-12-31 | 4.86M shares 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | 5.35M shares 10-Q · filed 2017-11-03 | 4.72M shares 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | 4.64M shares 10-Q · filed 2017-07-28 | 4.41M shares 10-Q · filed 2017-07-28 | |||
| 2016-03-31 | 4.19M shares 10-Q · filed 2017-05-05 | ||||
| 2015-12-31 | 3.56M shares 10-K · filed 2018-02-21 | ||||
| 2015-09-30 | 3.84M shares 10-Q · filed 2016-11-08 | 3.37M shares 10-Q · filed 2016-11-08 | |||
| 2015-06-30 | 3.23M shares 10-Q · filed 2016-08-09 | 3.14M shares 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | 3.06M shares 10-Q · filed 2016-05-10 | ||||
| 2014-12-31 | 4.54M shares 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | 3.12M shares 10-Q · filed 2015-11-10 | 5.05M shares 10-Q · filed 2015-11-10 | |||
| 2014-06-30 | 2.91M shares 10-Q · filed 2015-08-14 | 6.04M shares 10-Q · filed 2015-08-14 | |||
| 2014-03-31 | 9.20M shares 10-Q · filed 2015-05-12 | 2.67M shares 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | 21.82M shares 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | 21.66M shares 10-Q · filed 2014-11-10 | 21.82M shares 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | 21.85M shares 10-Q · filed 2014-08-11 | 21.90M shares 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | 21.96M shares 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | 12.01M shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |